Products - Ear, nose and throat conditions | Topic | NICE

Showing 9 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: In developmentRemove ‘Status: In development’ filter

Benralizumab for previously treated severe nasal polyps [ID1659]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 August 2026
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Digital technologies to support monitoring of vision change at home for people with age-related macular degeneration: early use assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
15 September 2026
Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
18 February 2026
Hearing aids for adults with hearing loss
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
27 January 2027
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps ID6379
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
9 September 2026
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC